BWAY Brainsway Ltd.
$13.93▲ +0.14%
Healthcare
Other
After hours
$13.93▲ +0.00%
Sep 11, 4:15 PM ET
Volume 68.0K
Avg Volume (10D) 83.6K
Key Metrics & Fundamentals
Market Cap
$560.10M
P/E Ratio
60.6
Div Yield
–%
52W Range
7.14 - 17.40
% vs 50 MA
-7.77%
% vs 200 MA
3.97%
RSI-14
40.8
MACD Histogram
-0.0400
Beta (1Y vs SPY)
1.98
Free Cash Flow
$5.42M
Gross Rev
$17.11M
Gross Profit
$12.77M
EBITDA
$4.24M
COGS
$4.34M
Operating Exp
$10.38M
Operating Income
$2.39M
EBIT
$2.39M
Pretax Income
$2.92M
Net Income
$2.71M
EPS (Diluted)
0.07
Price & Volume History
Loading chart…
Recent News
BrainsWay’s (BWAY) Growth Streak Just Got Harder To Ignore
Insider Monkey · Sep 11, 2026 2:56 AM
Are Options Traders Betting on a Big Move in Brainsway Stock?
Zacks · Sep 9, 2026 5:58 PM
BrainsWay Reports Promising Pilot Study Results in Patients with Depression and Comorbid Early-Stage Alzheimer’s Disease Treated with Deep TMS™
GlobeNewswire · Sep 8, 2026 11:30 AM
Wall Street Analysts See a 30.07% Upside in Brainsway (BWAY): Can the Stock Really Move This High?
Zacks · Aug 27, 2026 1:55 PM
BrainsWay Deep TMS™ Study Shows 70% Reduction in Patients Experiencing Suicidal Ideation
GlobeNewswire · Aug 27, 2026 11:30 AM
Brainsway (BWAY) Upgraded to Buy: Here's Why
Zacks · Aug 17, 2026 4:00 PM
Is Allogene Therapeutics (ALLO) Stock Outpacing Its Medical Peers This Year?
Zacks · Aug 17, 2026 1:40 PM
Brainsway Q2 Earnings Call Highlights
MarketBeat · Aug 13, 2026 9:02 AM
BrainsWay Ltd (BRSYF) (Q2 2026) Earnings Call Highlights: Revenue Surges 35% to $17. ...
GuruFocus.com · Aug 12, 2026 11:03 PM
BrainsWay Reports Second Quarter 2026 Financial Results and Operational Highlights
GlobeNewswire · Aug 12, 2026 11:30 AM
Financial Overview - Income Statement
Quarterly
Jun 2026
See BWAY's money flow as a full page
Social Sentiment
Avg +0.30 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.